ZOGENIX (ZGNX) Covered Calls

ZOGENIX covered calls Zogenix, Inc. is a pharmaceutical company, engaged in the commercializing and developing products for the treatment of central nervous system disorders and pain.

You can sell covered calls on ZOGENIX to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ZGNX (prices last updated Fri 4:16 PM ET):

ZOGENIX (ZGNX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
41.52 +0.17 38.25 41.68 386K - 1.5B
Covered Calls For ZOGENIX (ZGNX)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Nov 16 42 2.80 38.88 7.2% 90.6%
Jan 18 42 5.00 36.68 13.6% 54.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Zogenix, Inc. is a pharmaceutical company, which is engaged in commercializing and developing products for the treatment of central nervous system disorders and pain with novel drug delivery platforms. The company's product portfolio includes: Sumavel DosePro, Zohydro and Relday. The Sumavel DosePro product offers fast-acting, easy-to-use subcutaneous administration of sumatriptan for the acute treatment of migraine and cluster headache. The Zohydro product is a 12-hour extended-release formulation of hydrocodone without acetominophen for the treatment of moderate to severe chronic pain requiring around-the-clock opioid therapy. The Relday product is a proprietary, long-acting injectable formulation of risperidone using durect's SABER controlled-release formulation technology in combination with its DosePro needle-free, subcutaneous drug delivery system. Zogenix was founded by Stephen J. Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. Rigby and John J. Turanin on May 11, 2006 and is headquartered in San Diego, CA.